3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Cyclophosphamide
15
fludarabine phosphate
12
Filgrastim
10
Peripheral Blood Stem Cell Transplantation
9
ruxolitinib
8
Decitabine
8
fludarabine
7
Tacrolimus
7
Etoposide
7
Melphalan
6
Cytarabine
6
Azacitidine
6
Vorinostat
5
Mycophenolic Acid
5
Ipilimumab
5
venetoclax
4
Specimen Handling
4
Sirolimus
4
Idarubicin
4
Granulocyte Colony-Stimulating Factor
4
ivosidenib
3
fedratinib
3
aldesleukin
3
Whole-Body Irradiation
3
Rituximab
3
Radiotherapy
3
Nivolumab
3
Methylprednisolone
3
Imatinib Mesylate
3
Doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Myeloproliferative Disorders
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled